Alector (ALEC) FCF Margin (2018 - 2026)
Alector's (ALEC) quarterly FCF Margin came in at 1031.57% in Q2 2026, down 40855.0% year-over-year from N/an in Q2 2025, and up 78.39% quarter-over-quarter from 4773.52% in Q1 2026.
Analysis
Alector (ALEC) FCF Margin (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported FCF Margin for 9 consecutive years, with 1031.57% the latest figure, recorded in Q2 2026.
- On a quarterly basis, FCF Margin fell 40855.0% year-over-year to 1031.57% in Q2 2026; TTM through Jun 2026 was 1142.55%, a 87631.0% decrease from a year earlier, with the FY2025 full-year figure at 874.66%, down 64478.0% from the prior year.
- FCF Margin was 1031.57% for Q2 2026 at Alector, up from 4773.52% in the prior quarter.
- Over five years, FCF Margin peaked at 549.15% in Q1 2022 and troughed at 4773.52% in Q1 2026.
- A 5-year average of 688.6% and a median of 366.73% in 2022 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin soared 185426 bps in 2022 and slumped 311856 bps in 2026, its largest moves.
- Over 5 years, FCF Margin stood at 344.12% in 2022, then rose by 11 bps to 304.83% in 2023, then surged by 67 bps to 101.77% in 2024, then tumbled by 557 bps to 668.45% in 2025, then sank by 54 bps to 1031.57% in 2026.
- The last three FCF Margin figures came in at 1031.57% (Q2 2026), 4773.52% (Q1 2026), and 668.45% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 236.37 Bn | 222.38 Bn | 7.24 Bn | 34.70% |
| 2 | Gilead Sciences | 187.38 Bn | 184.12 Bn | 6.22 Bn | 44.00% |
| 3 | Vertex Pharmaceuticals | 138.36 Bn | 130.51 Bn | 2.84 Bn | 30.39% |
| 4 | Regeneron Pharmaceuticals | 85.09 Bn | 77.10 Bn | 3.93 Bn | 13.35% |
| 5 | Argenx Se | 63.93 Bn | 58.75 Bn | 1.37 Bn | - |
| 6 | Moderna | 58.07 Bn | 52.94 Bn | 52.00 Mn | -388.28% |
| 7 | Alnylam Pharmaceuticals | 35.59 Bn | 32.28 Bn | 992.69 Mn | 22.62% |
| 8 | Biogen | 32.63 Bn | 31.34 Bn | 1.96 Bn | 14.91% |
| 9 | Insmed | 27.57 Bn | 26.41 Bn | 358.27 Mn | -22.35% |
| 10 | Alector | 274.68 Mn | 101.88 Mn | - | -1,031.57% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,031.57% |
| Mar 31, 2026 | -4,773.52% |
| Dec 31, 2025 | -668.45% |
| Sep 30, 2025 | -997.61% |
| Jun 30, 2025 | -623.01% |
| Mar 31, 2025 | -1,654.95% |
| Dec 31, 2024 | -101.77% |
| Sep 30, 2024 | -332.07% |
| Jun 30, 2024 | -418.58% |
| Mar 31, 2024 | -389.35% |
| Dec 31, 2023 | -304.83% |
| Sep 30, 2023 | -509.89% |
| Jun 30, 2023 | -78.67% |
| Mar 31, 2023 | -299.55% |
| Dec 31, 2022 | -344.12% |
| Sep 30, 2022 | -343.17% |
| Jun 30, 2022 | -72.87% |
| Mar 31, 2022 | 549.15% |
| Dec 31, 2021 | -356.02% |
| Sep 30, 2021 | 243.48% |